YOLFTbeta
Meta Biomed Co. Ltd

Meta Biomed Co. Ltd

059210 · KQ · Healthcare / Healthcare Equipment & Supplies

3,595.00KRW-15.00 (-0.42%)

Price History

Full chart

Market Stats

Previous Close3,610.00
Open3,575.00
Day Range3,565.00 – 3,695.00
52-Week Range3,251.21 – 6,383.50
Volume91.44K
Market Cap96.91B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.62%
Beta0.99
50-Day Avg3,848.50
200-Day Avg4,262.78

About

Meta Biomed Co., Ltd. engages in the research and development, production, and marketing of dental and surgical materials in South Korea and internationally. The company's dental products include endodontics, endodontic materials, restorative materials, and bone graft materials. It also offers suture products comprising multifilament and monofilament products, as well as orthopedics; bone products consisting of bone graft substitutes and cement; and cosmetic medical products, as well as ultrasonic imaging diagnosis devices. The company was formerly known as Metadental Co., Ltd. and changed its name to Meta Biomed Co., Ltd. in 2001. Meta Biomed Co., Ltd. was founded in 1990 and is headquartered in Cheongju, South Korea.

Company Details

  • SectorHealthcare
  • IndustryHealthcare Equipment & Supplies
  • CEOMr. Seok-Song Oh
  • Employees255
  • Headquarters270 Osongsaengmyeong1-ro, Cheongju, South Korea, 281-61, Korea
  • Websitehttps://www.meta-biomed.com

Leadership

  • Mr. Seok-Song OhChief Exec. Officer and Representative Director · b. 1954
  • Min-Ha HwangChief Exec. Officer · b. 1956

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue27.09B44.79B63.52B61.36B68.59B65.78B65.34B52.59B59.39B47.21B58.78B68.94B83.10B94.04B102.95B
Growth (%)-+65.31%+41.83%-3.39%+11.78%-4.09%-0.67%-19.52%+12.94%-20.51%+24.51%+17.29%+20.54%+13.16%+9.48%
Cost of Revenue12.54B26.83B42.36B41.94B42.79B42.02B44.64B33.41B33.26B27.08B33.78B39.75B45.11B46.68B49.36B
Gross Profit---17.09B25.80B23.76B20.71B19.18B26.14B20.13B25.00B29.20B37.99B47.36B53.59B
Gross Margin---27.85%37.62%36.12%31.69%36.47%44.01%42.64%42.54%42.35%45.72%50.36%52.06%
Operating Expense---17.24B19.77B20.17B21.93B19.71B20.40B22.79B20.60B24.32B28.26B30.14B32.17B
Operating Income3.42B4.51B4.50B-155.15M6.04B3.60B-1.23B-536.89M5.74B-2.66B4.40B4.88B9.73B17.22B21.43B
Operating Margin12.62%10.07%7.09%-0.25%8.80%5.47%-1.88%-1.02%9.66%-5.64%7.49%7.08%11.71%18.31%20.81%
EBITDA-----------8.16B14.34B32.02B20.94B
EBITDA Margin-----------11.84%17.26%34.05%20.34%
Net Income1.18B2.33B2.17B-4.95B805.65M638.90M-4.10B-1.15B3.35B-4.09B9.52B2.63B10.08B22.40B10.99B
Net Income Margin4.35%5.20%3.42%-8.07%1.17%0.97%-6.28%-2.18%5.63%-8.67%16.20%3.81%12.12%23.82%10.67%
R&D948.56M-3.57B2.07B1.39B2.38B2.16B2.02B-2.24B3.34B4.34B4.54B5.14B4.97B
R&D as % of Total Revenue3.50%-5.62%3.37%2.03%3.62%3.30%3.83%-4.75%5.68%6.30%5.46%5.47%4.82%
Interest Expense0000000001.10B1.14B1.39B2.32B3.74B2.85B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%2.34%1.95%2.02%2.79%3.98%2.76%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets53.89B103.43B116.79B115.06B113.78B120.08B119.66B97.69B103.29B107.86B103.13B121.07B130.12B177.30B186.60B
Total Liabilities14.84B62.54B72.25B70.85B62.91B68.49B73.65B47.72B50.02B59.88B44.80B60.48B57.46B83.96B61.73B
Total Equity37.94B39.83B43.49B42.94B50.87B51.59B46.01B49.97B53.27B47.98B58.32B60.59B70.05B93.34B124.32B
Cash2.12B1.79B2.53B518.46M1.42B3.52B5.47B5.49B2.35B8.64B10.11B13.23B10.80B14.52B17.96B
Total Debt----30.23B50.39B58.11B34.79B38.12B48.56B-----
Net Debt---------40.76B24.09B30.57B33.11B40.74B24.08B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow4.10B3.83B3.71B-296.24M4.93B5.03B-248.51M-5.28B2.86B4.86B11.14B9.16B10.22B22.63B19.83B
Investing Cash Flow----3.10B1.50B-6.18B-5.16B23.19B-6.73B-9.92B6.32B-14.58B-11.70B-43.36B-
Financing Cash Flow-9.60B11.91B1.37B-5.25B3.14B7.47B-17.93B674.26M11.40B-16.11B8.73B-1.02B23.41B-
Capital Expenditure8.22B5.26B4.60B4.16B7.79B6.13B8.80B9.08B7.56B2.23B2.07B15.41B11.49B11.10B20.46B
Free Cash Flow---------1.55B9.04B-6.25B-1.28B11.53B-627.91M
Dividends Paid150.97M256.50M254.09M254.09M187.76M213.59M215.41M215.04M233.28M232.67M229.01M458.02M457.42M457.42M684.93M
FCF to OCF---------31.84%81.14%-68.19%-12.50%50.95%-3.17%
Dividend Paid to FCF---------15.03%2.53%-7.33%-35.82%3.97%-109.08%

Earnings

Report DateMar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 12, 2016Nov 15, 2016Mar 7, 2017May 15, 2017Aug 11, 2017Nov 14, 2017Mar 14, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 13, 2019May 15, 2019Aug 14, 2019Nov 13, 2019Mar 18, 2020May 14, 2020Aug 14, 2020Nov 13, 2020Mar 17, 2021Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Nov 14, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------------------------978.00---
EPS Actual105.6898.0117.08-6.7035.4413.7142.87-31.7741.8767.55-50.9531.8028.9221.0055.8919.5982.665.312.1810.71-50.41-16.73-210.0040.77-0.4613.91-22.1020.7950.3548.57-81.0027.16-12.0089.70-304.39106.064.8024.75-148.14-18.9357.1226.5679.15-23.00-92.0029.00-91.2664.39137.8242.30171.2540.40127.87-22.17-31.40161.5454.37137.2187.52249.8089.28144.23396.27211.25-36.50143.0061.87166.66190.91
Surprise------------------------------------------------------------------85.38%---
Timing----------------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hours-Pre-marketPre-market------------------Pre-market---

Key Statistics & Ratios

Market Cap96.91B
Enterprise Value104.23B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.99
Price / Book0.74
Revenue (TTM)66.88B
Gross Profit (TTM)25.00B
EBITDA9.50B
Profit Margin10.87%
Operating Margin8.95%
Return on Equity2568.12%
Return on Assets3.14%
Shares Outstanding23.49M
Shares Float17.13M
Beta0.99
Dividend Yield0.62%
Dividend Rate0.00
Payout Ratio28.45%

Dividends

20261×
55.00Jun 29, 2026
20251×
105.00Dec 29, 2025
20241×
30.00Dec 27, 2024
20231×
20.00Dec 27, 2023
20221×
20.00Dec 28, 2022
20211×
20.00Dec 29, 2021
20201×
10.00Dec 29, 2020
20191×
10.00Dec 27, 2019
20181×
10.00Dec 27, 2018
20171×
10.00Dec 27, 2017
20161×
10.00Dec 28, 2016
20151×
10.00Dec 29, 2015
20141×
10.00Dec 29, 2014
20131×
15.00Dec 27, 2013
20121×
15.00Dec 27, 2012
20111×
15.00Dec 28, 2011
20101×
10.00Dec 29, 2010
20091×
42.15Dec 29, 2009
20081×
31.61Dec 29, 2008

Stock Splits

  • Apr 23, 20102:1
  • Mar 18, 2010637:537